PFPT has proven to be an effective tool for reducing SUI symptoms and improving quality of life. However,
women living in remote areas, or who cannot afford, do not wish to access, or have otherwise limited access
to PFPT may need alternative treatment options to gain the same benefits of monitored pelvic floor
rehabilitation. The goal of the study was also to support the implementation of personal biofeedback
devices to overcome issues with patient distance and ability to maintain clinician monitoring. The PeriCoach
feature set of technique guidance technology, the unique ability to measure muscle strength directly,
comprehensive measurement and data analytics, and clinical connectivity features were able to meet these
challenges.
The primary outcome measurement was met, with the biofeedback group using PeriCoach demonstrating
non-inferiority to PFPT based on quality of life score as measured by the International Consultation on
Incontinence Questionnaire short form (ICIQ-SF). For the primary outcome of change in ICIQ-SF scores
(where lower scores indicate less urinary incontinence), the home biofeedback group using PeriCoach was
found to be non-inferior to PFPT [-4.73 (-3.21 to -6.25) vs -3.95 (-2.21 to -5.70), p= 0.009].
Dr Michael Monsour, Chairman of Analytica said “This work by Dr de Winter confirms my own clinical
experience in regional Queensland and the real-world data we’ve collected from thousands of
women. Whilst the gold standard is in-person consultations, for those women who are too remote, can’t
afford multiple visits, or are just too time poor, the PeriCoach offers treatment that’s now proven to be onpar with specialised clinician treatment in most instances.
ALT Price at posting:
0.2¢ Sentiment: None Disclosure: Held
